Showing 9551-9560 of 21412 results for "".
ISDPA: Dr. Bhatia on JAK Inhibitors
https://reachmd.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
https://reachmd.com/programs/cme/building-the-team-integrating-immunotherapy-into-multidisciplinary-care/60854/Experts explore emerging evidence and multidisciplinary integration of perioperative immunotherapy for resectable, locally advanced HNSCC."A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
https://reachmd.com/programs/the-convergence/ultrasound-clement-papadacci-inserm/39926/4D ultrasound and ultrasound localization microscopy (ULM) are reshaping non-invasive imaging, allowing clinicians to visualize entire organs—down to vessels smaller than a human hair—in dynamic, real-time detail. Dr. Clément Papadacci joins Dr. Brian McDonough to share how his groundbreaking probeThe Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
https://reachmd.com/programs/cme/the-sequencing-puzzle-integrating-oral-serds-and-protacs-into-the-mbc-treatment-landscape/67124/Explore clinical strategies for oral SERDs and PROTACs in ER+/HER2− metastatic breast cancer, including sequencing, safety, and treatment selection.Managing Immune-Related Adverse Events in Metastatic NSCLC
https://reachmd.com/programs/project-oncology/managing-iraes-metastatic-nsclc/49119/Immunotherapy-based combination regimens continue to transform the treatment landscape for metastatic non-small cell lung cancer (NSCLC). However, long-term safety findings from trials like KEYNOTE-189, CheckMate 9LA, and IMpower150 show that grade 3 or higher immune-related adverse events can occurHow Selective Photothermolysis Was Introduced in Dermatology
https://reachmd.com/programs/modern-aesthetics-focus-on-energy-based-devices/talking-fractional-lasers-with-the-inventor/56541/Laser pioneer R. Rox Anderson, MD, FAAD, joins Modern Aesthetics March/April Guest Medical Editor Jill Waibel, FACS, FAAD, to discuss the invention of fractional lasers and the impact of that technology on the field.Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
https://reachmd.com/programs/project-oncology/bringing-cancer-care-home-how-subcutaneous-immunotherapy-can-help-ease-the-burden/35770/As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care forComprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
https://reachmd.com/programs/neurofrontiers/comprehensive-care-navigating-neurobehavioral-issues-in-dmd-patients/16502/Here are some best practices for managing the 70 percent of patients with Duchenne muscular dystrophy who also have a neurobehavioral issue.Matching TNBC Treatment Intensity to Patient Needs
https://reachmd.com/programs/project-oncology/matching-tnbc-treatment-intensity-patient-needs/50995/As most patients with early-stage triple-negative breast cancer (TNBC) receive multiple systemic therapies before surgery, an important question remains: how can treatment intensity be better aligned with individual patient needs? That was the focus of Dr. Roberto Leon-Ferre’s session at the 2026 AmHow Advances in Immunology Are Shaping CSU Care
https://reachmd.com/programs/on-the-frontlines-of-chronic-spontaneous-urticaria/how-advances-in-immunology-are-shaping-csu-care/56724/Chronic spontaneous urticaria (CSU) involves distinct immune mechanisms that set it apart from other inflammatory skin diseases, and advances in our understanding of cytokines and mast cell activation are reshaping how clinicians approach its diagnosis and treatment. Joining Dr. Steve Jackson to exp